Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 12743244.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
One hundred seventy-six consecutive patients treated with IV tissue plasminogen activator (tPA) for acute ischemic stroke were examined prospectively, and orolingual angioedema was found in nine (5.1%; 95% CI 2.3 to 9.5). The reaction was typically mild, transient, and contralateral to the ischemic hemisphere. Risk of angioedema was associated with angiotensin-converting enzyme inhibitors (relative risk [RR] 13.6; 95% CI 3.0 to 62.7) and signs on initial CT of ischemia in the insular and frontal cortex (RR 9.1; 95% CI 1.4 to 30.0).
Medical subject headings
- Angioedema
- Angiotensin-Converting Enzyme Inhibitors
- Antihypertensive Agents
- Fibrinolytic Agents
- Stroke
- Tissue Plasminogen Activator